The questions answered in this podcast are listed below.
They were compiled by GPs and professional attendees at our face-to-face seminars around Australia.

1. What factors influence your choice of oral contraceptive pill for someone starting the pill for the first time?
2. What is the current first-line OCP choice for adolescents with heavy menstrual bleeding?
3. For women with PMOS (previously known as PCOS), why are cyproterone acetate-containing pills no longer considered first-line therapy, and what alternatives would you recommend?
4. What is the mental health impact of different OCPs?
5. How should cardiovascular risk influence OCP prescribing in women over 40?
6. Can women continue combined OCPs into their 50s?
7. How can menopause be confirmed in a woman who is taking the combined OCP?
8. When should older women be transitioned from OCP to MHT?
9. Does a family history of breast cancer influence the choice of OCP or MHT?
10. Can a Mirena be used as the progestogen component of MHT, and when does it need to be replaced?
11. Why can’t estrogen simply be added for a woman using a Kyleena, rather than a Mirena?
12. Can women safely use MHT if they have a history of VTE or a strong family history of thrombosis?
13. What is the thrombosis risk associated with Bijuva?

Expert: A/Prof Gino Pecoraro OAM, Obstetrician and Gynaecologist

Host: Dr Terri Foran, GP & Sexual Health Physician

Total time: 36 mins

Recommended resources

• Jean Hailes for Women
• Australasian Menopause Society